Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 10/20 | 0.47 |
| ▸ | BCHE | P06276 | 9/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | TTR | P02766 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6035326 | 0.99 | ACHE (0.49) | ACHEBCHENPC1TTR | |
| Hydrochloric Acid SCHEMBL4860098 | 0.99 | ACHE (0.47) | ACHEBCHENPC1TTRRAB9A | |
| Hydrochloric Acid SCHEMBL4858639 | 0.98 | ACHE (0.48) | ACHEBCHENPC1TTR | |
| SCHEMBL13987335 | 0.96 | ACHE (0.47) | ACHEBCHE | |
| SCHEMBL13987349 | 0.95 | ACHE (0.48) | ACHEBCHE | |
| Hydrochloric Acid SCHEMBL5987556 | 0.95 | ACHE (0.46) | ACHEBCHE | |
| Hydrochloric Acid SCHEMBL4860358 | 0.94 | ACHE (0.47) | ACHEBCHE | |
| SCHEMBL13987275 | 0.91 | ACHE (0.48) | ACHEBCHE | |
| SCHEMBL13987309 | 0.91 | NPC1 (0.49) | ACHEBCHENPC1TTRRAB9A | |
| SCHEMBL13987302 | 0.90 | ACHE (0.49) | ACHEBCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7462628-B2 | Preventives/remedies for urinary disturbance | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-12-09 | — | — | US | disclosed |
| US-7462628-B2 | Preventives/remedies for urinary disturbance | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-12-09 | — | — | US | disclosed |
| US-20060063769-A1 | Preventives/remedies for urinary disturbance | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060063769-A1 | Preventives/remedies for urinary disturbance | ACHE, BPHL, CHRM1 | ACHE 1/4885BCHE 23/4885NPC1 1160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.